Maple Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,499
| Closed | -$447K | – | 128 |
|
|
2019
Q3 | $447K | Buy |
4,499
+2,145
| +91% | +$204K | 0.1% | 80 |
|
|
2019
Q2 | $218K | Sell |
2,354
-1,021
| -30% | -$97K | 0.05% | 113 |
|
|
2019
Q1 | $318K | Sell |
3,375
-625
| -16% | -$54.7K | 0.07% | 94 |
|
|
2018
Q4 | $256K | Sell |
4,000
-409
| -9% | -$30.2K | 0.07% | 104 |
|
|
2018
Q3 | $395K | Sell |
4,409
-1,690
| -28% | -$149K | 0.09% | 93 |
|
|
2018
Q2 | $484K | Hold |
6,099
| – | – | 0.12% | 86 |
|
|
2018
Q1 | $544K | Sell |
6,099
-245
| -4% | -$23.5K | 0.14% | 81 |
|
|
2017
Q4 | $662K | Hold |
6,344
| – | – | 0.17% | 74 |
|
|
2017
Q3 | $925K | Buy |
6,344
+145
| +2% | +$19.8K | 0.25% | 64 |
|
|
2017
Q2 | $805K | Hold |
6,199
| – | – | 0.23% | 66 |
|
|
2017
Q1 | $771K | Sell |
6,199
-726
| -10% | -$86.9K | 0.23% | 68 |
|
|
2016
Q4 | $802K | Buy |
6,925
+965
| +16% | +$107K | 0.25% | 61 |
|
|
2016
Q3 | $623K | Hold |
5,960
| – | – | 0.2% | 74 |
|
|
2016
Q2 | $588K | Sell |
5,960
-30
| -0.5% | -$3.1K | 0.22% | 66 |
|
|
2016
Q1 | $600K | Sell |
5,990
-95
| -2% | -$9.78K | 0.22% | 64 |
|
|
2015
Q4 | $729K | Buy |
6,085
+200
| +3% | +$23.1K | 0.26% | 70 |
|
|
2015
Q3 | $637K | Buy |
5,885
+1,235
| +27% | +$153K | 0.24% | 71 |
|
|
2015
Q2 | $538K | Hold |
4,650
| – | – | 0.18% | 79 |
|
|
2015
Q1 | $536K | Sell |
4,650
-180
| -4% | -$21.5K | 0.19% | 79 |
|
|
2014
Q4 | $540K | Buy |
+4,830
| New | +$509K | 0.2% | 78 |
|
Other funds holding CELG
Maple Capital Management's CELG Position: Q4 2019 in Review
Maple Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,499 shares — an estimated $447K sold.
Maple Capital Management first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $925K in Q3 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Maple Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Maple Capital Management sold 4,499 Celgene Corp shares in Q4 2019, an estimated $447K.
- Maple Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
- Maple Capital Management's Celgene Corp position peaked at $925K in Q3 2017.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Maple Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.